• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过水溶液中的原子力显微镜分析揭示普罗布考在纳米颗粒中的结晶

Crystallization of Probucol in Nanoparticles Revealed by AFM Analysis in Aqueous Solution.

作者信息

Egami Kiichi, Higashi Kenjirou, Yamamoto Keiji, Moribe Kunikazu

机构信息

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

出版信息

Mol Pharm. 2015 Aug 3;12(8):2972-80. doi: 10.1021/acs.molpharmaceut.5b00236. Epub 2015 Jul 7.

DOI:10.1021/acs.molpharmaceut.5b00236
PMID:26106951
Abstract

The crystallization behavior of a pharmaceutical drug in nanoparticles was directly evaluated by atomic force microscopy (AFM) force curve measurements in aqueous solution. A ternary spray-dried sample (SPD) was prepared by spray drying the organic solvent containing probucol (PBC), hypromellose (HPMC), and sodium dodecyl sulfate (SDS). The amorphization of PBC in the ternary SPD was confirmed by powder X-ray diffraction (PXRD) and solid-state 13C NMR measurements. A nanosuspension containing quite small particles of 25 nm in size was successfully prepared immediately after dispersion of the ternary SPD into water. Furthermore, solution-state 1H NMR measurements revealed that a portion of HPMC coexisted with PBC as a mixed state in the freshly prepared nanosuspension particles. After storing the nanosuspension at 25 °C, a gradual increase in the size of the nanoparticles was observed, and the particle size changed to 93.9 nm after 7 days. AFM enabled the direct observation of the morphology and agglomeration behavior of the nanoparticles in water. Moreover, AFM force-distance curves were changed from (I) to (IV), depending on the storage period, as follows: (I) complete indentation within an applied force of 1 nN, (II) complete indentation with an applied force of 1-5 nN, (III) partial indentation with an applied force of 5 nN, and (IV) nearly no indentation with an applied force of 5 nN. This stiffness increase of the nanoparticles was attributed to gradual changes in the molecular state of PBC from the amorphous to the crystal state. Solid-state 13C NMR measurements of the freeze-dried samples demonstrated the presence of metastable PBC Form II crystals in the stored nanosuspension, strongly supporting the AFM results.

摘要

通过水溶液中的原子力显微镜(AFM)力曲线测量直接评估了药物在纳米颗粒中的结晶行为。通过喷雾干燥含有普罗布考(PBC)、羟丙甲纤维素(HPMC)和十二烷基硫酸钠(SDS)的有机溶剂制备了三元喷雾干燥样品(SPD)。通过粉末X射线衍射(PXRD)和固态13C NMR测量证实了三元SPD中PBC的非晶化。将三元SPD分散到水中后,立即成功制备出了含有尺寸为25 nm的非常小颗粒的纳米悬浮液。此外,溶液态1H NMR测量表明,在新制备的纳米悬浮颗粒中,一部分HPMC与PBC以混合状态共存。将纳米悬浮液在25℃下储存后,观察到纳米颗粒尺寸逐渐增加,7天后粒径变为93.9 nm。AFM能够直接观察水中纳米颗粒的形态和团聚行为。此外,AFM力-距离曲线根据储存时间从(I)变为(IV),如下:(I)在1 nN的作用力下完全压入,(II)在1 - 5 nN的作用力下完全压入,(III)在5 nN的作用力下部分压入,(IV)在5 nN的作用力下几乎没有压入。纳米颗粒这种硬度的增加归因于PBC分子状态从非晶态到晶态的逐渐变化。对冻干样品的固态13C NMR测量表明,在储存的纳米悬浮液中存在亚稳的PBC晶型II晶体,有力地支持了AFM结果。

相似文献

1
Crystallization of Probucol in Nanoparticles Revealed by AFM Analysis in Aqueous Solution.通过水溶液中的原子力显微镜分析揭示普罗布考在纳米颗粒中的结晶
Mol Pharm. 2015 Aug 3;12(8):2972-80. doi: 10.1021/acs.molpharmaceut.5b00236. Epub 2015 Jul 7.
2
Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.冷冻透射电子显微镜和原子力显微镜观察三元固体分散体水分散体中无定形普罗布考纳米颗粒的时变演变。
Mol Pharm. 2019 May 6;16(5):2184-2198. doi: 10.1021/acs.molpharmaceut.9b00158. Epub 2019 Apr 9.
3
Structural evaluation of probucol nanoparticles in water by atomic force microscopy.原子力显微镜法评估水中普罗布考纳米粒的结构。
Int J Pharm. 2012 May 10;427(2):365-71. doi: 10.1016/j.ijpharm.2012.02.020. Epub 2012 Feb 20.
4
Molecular-level characterization of probucol nanocrystal in water by in situ solid-state NMR spectroscopy.采用原位固态 NMR 光谱法对水中普罗布考纳米晶体进行分子水平表征。
Int J Pharm. 2012 Feb 28;423(2):571-6. doi: 10.1016/j.ijpharm.2011.11.028. Epub 2011 Nov 26.
5
Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersion.揭示三元固体分散体水分散体形成的无定形药物纳米颗粒形态变化的机制。
Int J Pharm. 2021 Sep 25;607:120984. doi: 10.1016/j.ijpharm.2021.120984. Epub 2021 Aug 11.
6
Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.从普罗布考/聚乙烯吡咯烷酮/十二烷基硫酸钠三元研磨混合物中获得的胶体纳米颗粒的形成机制。
Int J Pharm. 2008 Mar 20;352(1-2):309-16. doi: 10.1016/j.ijpharm.2007.10.052. Epub 2007 Nov 9.
7
In situ molecular elucidation of drug supersaturation achieved by nano-sizing and amorphization of poorly water-soluble drug.通过难溶性药物的纳米化和无定形化实现药物过饱和的原位分子阐释
Eur J Pharm Sci. 2015 Sep 18;77:79-89. doi: 10.1016/j.ejps.2015.05.027. Epub 2015 May 30.
8
Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles.采用热熔挤出法制备三元无定形固体分散体以获得无定形普罗布考纳米粒子的稳定胶体分散体。
Int J Pharm. 2023 Jun 10;640:122959. doi: 10.1016/j.ijpharm.2023.122959. Epub 2023 Apr 20.
9
Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR.通过固态核磁共振研究普罗布考/聚乙烯吡咯烷酮/十二烷基硫酸钠多组分体系中的分子相互作用。
Pharm Res. 2006 Nov;23(11):2566-74. doi: 10.1007/s11095-006-9089-z. Epub 2006 Sep 13.
10
Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.应用纳米混悬技术制备抗坏血酸棕榈酸酯纳米晶体
Int J Pharm. 2008 Apr 16;354(1-2):227-34. doi: 10.1016/j.ijpharm.2007.11.062. Epub 2007 Dec 15.

引用本文的文献

1
Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?无定形固体分散体诱导的富药相:口服给药中的随意目标还是有意为之?
Pharmaceutics. 2021 Jun 15;13(6):889. doi: 10.3390/pharmaceutics13060889.
2
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.无定形固体分散体以及纳米颗粒对体外溶出和体内测试的贡献:以氯硝柳胺为例的研究
Pharmaceutics. 2021 Jan 14;13(1):97. doi: 10.3390/pharmaceutics13010097.
3
Temperature-Induced Surface Effects on Drug Nanosuspensions.
温度诱导的药物纳米混悬剂表面效应。
Pharm Res. 2018 Feb 21;35(3):69. doi: 10.1007/s11095-017-2300-6.